321 related articles for article (PubMed ID: 32547947)
1. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Liu S; Wang W; Zhao Y; Liang K; Huang Y
Front Oncol; 2020; 10():809. PubMed ID: 32547947
[No Abstract] [Full Text] [Related]
2. Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining.
Liu K; Chen Y; Feng P; Wang Y; Sun M; Song T; Tan J; Li C; Liu S; Kong Q; Zhang J
Front Genet; 2022; 13():854531. PubMed ID: 35360870
[No Abstract] [Full Text] [Related]
3. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
[TBL] [Abstract][Full Text] [Related]
4. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
5. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
[TBL] [Abstract][Full Text] [Related]
6. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate hub genes correlated with the pathogenesis, diagnosis, and prognosis of prostate cancer by integrated bioinformatics analysis.
Wei T; Liang Y; Anderson C; Zhang M; Zhu N; Xie J
Transl Cancer Res; 2022 Oct; 11(10):3548-3571. PubMed ID: 36388030
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
9. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.
Chen X; Ma J; Xu C; Wang L; Yao Y; Wang X; Zi T; Bian C; Wu D; Wu G
Discov Oncol; 2022 Jun; 13(1):54. PubMed ID: 35768705
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.
He Z; Duan X; Zeng G
PeerJ; 2019; 7():e7872. PubMed ID: 31598425
[TBL] [Abstract][Full Text] [Related]
12. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
Su Q; Dai B; Zhang H; Zhang S
Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
[TBL] [Abstract][Full Text] [Related]
13. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
16. The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.
Song Z; Huang Y; Zhao Y; Ruan H; Yang H; Cao Q; Liu D; Zhang X; Chen K
J Cancer; 2019; 10(6):1398-1408. PubMed ID: 31031850
[No Abstract] [Full Text] [Related]
17. Correlation of NTRK1 Downregulation with Low Levels of Tumor-Infiltrating Immune Cells and Poor Prognosis of Prostate Cancer Revealed by Gene Network Analysis.
Bagherabadi A; Hooshmand A; Shekari N; Singh P; Zolghadri S; Stanek A; Dohare R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627227
[TBL] [Abstract][Full Text] [Related]
18. [Bioinformatics-based identification of the key genes associated with prostate cancer].
Zhao HB; Xu GB; Yang WQ; Li XZ; Chen SX; Gan Y; Su ZM; Sheng M; Zeng YR
Zhonghua Nan Ke Xue; 2021 Jun; 27(6):489-498. PubMed ID: 34914287
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
Cheng Y; Qi F; Li L; Qin Z; Li X; Wang X
Transl Androl Urol; 2020 Dec; 9(6):2616-2628. PubMed ID: 33457234
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
